Sellas Life Sciences Group Inc (SLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SLS? Forum Prognose Aktiensplit

Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Selling, General, and Administrative	4.50% 2.867	3.002	2.858	2.481	2.967
Costs And Expenses	3.06% 7.083	6.873	6.063	6.918	7.329
Operating Income/Loss	3.06% -7.083	-6.873	-6.063	-6.918	-7.329
Nonoperating Income/Loss	7.35% 0.292	0.272	0.25	0.181	0.221
Income/Loss From Continuing Operations Before Tax	3.06% -7.083	-6.873	-6.063	-6.286	-7.329
Income/Loss From Continuing Operations After Tax	2.88% -6.791	-6.601	-5.813	-6.737	-7.108
Net Income/Loss	2.88% -6.791	-6.601	-5.813	-6.737	-7.108
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9.98% 108.40	98.56	87.76	4.2618	68.25
Diluted Average Shares	9.98% 108.40	98.56	87.76	4.2618	68.25
Basic Earnings Per Share	14.29% -0.06	-0.07	-0.07	-0.08	-0.10
Diluted Earnings Per Share	14.29% -0.06	-0.07	-0.07	-0.08	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-